General Psychedelics:

• Psychedelics as potent anti-inflammatory therapeutics - Neuropharmacology, 2022

• The Potential of Psychedelics for End of Life and Palliative Care - Disruptive Psychopharmacology, 2021

• Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies - BMC Palliative Care, 2021

• Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy - Frontiers in Psychiatry, 2021

Ketamine:

• Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review - Harvard Review of Psychiatry, 2021

• Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder - Translational Psychiatry, 2021

• The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research - Neuroscience and Biobehavioral Reviews, 2021

• Ketamine infusion therapy in treatment-resistant depression - Psychiatriki, 2021

• Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis - International Review of Psychiatry, 2020

• Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation - Science, 2019

Psilocybin:

• Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up - Journal of Psychopharmacology, 2022

• Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression - Journal of Psychoactive Drugs, 2022

• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial - JAMA Psychiatry, 2021

• Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin - British Journal of Psychiatry, 2018

MDMA:

• MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study - Nature Medicine, 2021

• Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems - Frontiers in Psychiatry, 2021

• Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices - Journal of Psychopharmacology, 2015